Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cytomegalovirus Infection

  Free Subscription


Articles published in Transplant Proc

Retrieve available abstracts of 37 articles:
HTML format
Text format



Single Articles


    December 2018
  1. MAJEED A, Latif A, Kapoor V, Sohail A, et al
    Resistant Cytomegalovirus Infection in Solid-organ Transplantation: Single-center Experience, Literature Review of Risk Factors, and Proposed Preventive Strategies.
    Transplant Proc. 2018;50:3756-3762.
    PubMed     Text format     Abstract available


  2. CZARNECKA P, Czarnecka K, Tronina O, Durlik M, et al
    Cytomegalovirus Disease After Liver Transplant-A Description of a Treatment-Resistant Case: A Case Report and Literature Review.
    Transplant Proc. 2018;50:4015-4022.
    PubMed     Text format     Abstract available


  3. NAWASHIRO Y, Shiraki K, Yamamoto S, Takizawa K, et al
    Persistent Primary Cytomegalovirus Infection After Deceased Donor Kidney Transplant: Ganciclovir Susceptibility of Human Cytomegalovirus With UL97 D605E Mutation: A Case Report.
    Transplant Proc. 2018;50:3932-3936.
    PubMed     Text format     Abstract available


  4. SANDKOVSKY U, Qiu F, Kalil AC, Florescu A, et al
    Risk Factors for the Development of Cytomegalovirus Resistance in Solid Organ Transplantation: A Retrospective Case-Control Study.
    Transplant Proc. 2018;50:3763-3768.
    PubMed     Text format     Abstract available


  5. NUGROHO A, Lee KW, Kim H, Yi NJ, et al
    Challenging Alveolar Hemorrhage Complicating Pneumonia After Liver Transplantation: A Case Report.
    Transplant Proc. 2018;50:4046-4049.
    PubMed     Text format     Abstract available


    September 2018
  6. OSIAK M, Szubinska-Lelonkiewicz D, Wychowanski P, Karakulska-Prystupiuk E, et al
    Frequency of Pathologic Changes in the Oral Cavity in Patients Subjected to Long-term Pharmacologic Immunosuppressive Therapy After Kidney, Liver, and Hematopoietic Cell Transplantation.
    Transplant Proc. 2018;50:2176-2178.
    PubMed     Text format     Abstract available


    July 2018
  7. KOMOROWSKA-JAGIELSKA K, Heleniak Z, Debska-Slizien A
    Cytomegalovirus Status of Kidney Transplant Recipients and Cardiovascular Risk.
    Transplant Proc. 2018;50:1868-1873.
    PubMed     Text format     Abstract available


    June 2018
  8. HWANG SD, Lee JH, Lee SW, Kim JK, et al
    Effect of Low-Dose Vs Standard-Dose Valganciclovir in the Prevention of Cytomegalovirus Disease in Kidney Transplantation Recipients: A Systemic Review and Meta-Analysis.
    Transplant Proc. 2018 Jun 2. pii: S0041-1345(18)30067.
    PubMed     Text format     Abstract available


  9. BODRO M, Sanclemente G, Crespo G, Linares L, et al
    Severe Hepatitis C Recurrence as a Risk Factor for Opportunistic Infections in Liver Transplant Recipients.
    Transplant Proc. 2018;50:1437-1443.
    PubMed     Text format     Abstract available


  10. LEE H, Lee S, Jeon JS, Kwon SH, et al
    Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience.
    Transplant Proc. 2018;50:1285-1288.
    PubMed     Text format     Abstract available


    May 2018
  11. PARK WY, Kang SS, Jin K, Park SB, et al
    Is the Clinical Outcome Good or Bad in Patients Hospitalized Within 1 Year After Kidney Transplantation?
    Transplant Proc. 2018;50:1001-1004.
    PubMed     Text format     Abstract available


    April 2018
  12. LEE JH, Hwang SD, Song JH, Kim JH, et al
    Efficacy of Ultralow-Dose Valganciclovir Chemoprophylaxis for Cytomegalovirus Infection in ABO-Incompatible Kidney Transplantation Recipients.
    Transplant Proc. 2018 Apr 11. pii: S0041-1345(18)30575.
    PubMed     Text format     Abstract available


  13. NANMOKU K, Shinzato T, Kubo T, Shimizu T, et al
    Steroid Withdrawal Using Everolimus in ABO-Incompatible Kidney Transplant Recipients With Post-Transplant Diabetes Mellitus.
    Transplant Proc. 2018 Apr 6. pii: S0041-1345(18)30096.
    PubMed     Text format     Abstract available


  14. BOND MMK, Bond MMK, Sehn A, Dias VH, et al
    Cyclosporine Versus Tacrolimus: Which Calcineurin Inhibitor Has Influence on Cytomegalovirus Infection in Cardiac Transplantation?
    Transplant Proc. 2018;50:809-814.
    PubMed     Text format     Abstract available


    March 2018
  15. DE GRACIA-GUINDO MDC, Ruiz-Fuentes MDC, Galindo-Sacristan P, Osorio-Moratalla JM, et al
    Cytomegalovirus Infection Monitoring Based on Interferon Gamma Release Assay in Kidney Transplantation.
    Transplant Proc. 2018;50:578-580.
    PubMed     Text format     Abstract available


  16. CINTRA-CABRERA M, Suarez-Benjumea A, Bernal-Blanco G, Gonzalez-Roncero FM, et al
    Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review.
    Transplant Proc. 2018;50:575-577.
    PubMed     Text format     Abstract available


    January 2018
  17. BARADHI KM, Aure RL, El-Amm JM
    High-dose Valganciclovir Treatment for Resistant Cytomegalovirus Colitis due to UL97 and UL54 Mutations.
    Transplant Proc. 2018;50:142-144.
    PubMed     Text format     Abstract available


  18. NANMOKU K, Shinzato T, Kubo T, Shimizu T, et al
    Prevention of Late-Onset Cytomegalovirus Infection and Disease in Donor-Positive/Recipient-Negative Kidney Transplant Recipients Using Low-Dose Valganciclovir.
    Transplant Proc. 2018;50:124-129.
    PubMed     Text format     Abstract available


    December 2017
  19. HALLECK F, Khadzhynov D, Schrezenmeier E, Lehner L, et al
    Prolonged Low-Dose Prophylaxis With Valganciclovir in Cytomegalovirus-Negative Recipients of Kidney Transplants From Cytomegalovirus-Positive Donors Allows Seroconversion and Prevents Cytomegalovirus Disease.
    Transplant Proc. 2017;49:2280-2284.
    PubMed     Text format     Abstract available


    October 2017
  20. KAYA AH, Tekgunduz E, Akpinar S, Batgi H, et al
    Is Cytomegalovirus Surveillance Necessary for Patients With Low Reactivation Risk in an Autologous Hematopoietic Cell Transplantation Setting?
    Transplant Proc. 2017;49:1911-1915.
    PubMed     Text format     Abstract available


  21. FAVI E, Santangelo R, Iesari S, Morandi M, et al
    Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience.
    Transplant Proc. 2017;49:1766-1772.
    PubMed     Text format     Abstract available


    September 2017
  22. ECHENIQUE IA, Beltran D, Ramirez-Ruiz L, Najafian N, et al
    Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report.
    Transplant Proc. 2017;49:1560-1564.
    PubMed     Text format     Abstract available


    June 2017
  23. BRUMINHENT J, Rotjanapan P, Watcharananan SP
    Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Transplant Proc. 2017;49:1048-1052.
    PubMed     Text format     Abstract available


  24. HARADA S, Nakamura T, Ushigome H, Akutsu N, et al
    Beneficial Effects of High-Dose Mizoribine on ABO-Incompatible Living-Related Kidney Transplantation: Two-Year Results by a Japanese Multicenter Study.
    Transplant Proc. 2017;49:967-970.
    PubMed     Text format     Abstract available


    May 2017
  25. BRASIL IRC, Custodio-Lima J, Sampaio RL, Pierre AMM, et al
    Pre-emptive Therapy for Cytomegalovirus in Post-transplantation Liver Patients With Donor-Positive/Recipient-Negative Serostatus.
    Transplant Proc. 2017;49:871-873.
    PubMed     Text format     Abstract available


  26. PRETAGOSTINI R, Poli L, Lai Q, Russo G, et al
    Pre-Emptive Therapy for the Treatment of Cytomegalovirus After Kidney Transplantation.
    Transplant Proc. 2017;49:638-641.
    PubMed     Text format     Abstract available


  27. PULITI REIGADA CH, de Ataide EC, de Almeida Prado Mattosinho T, Boin IFSF, et al
    Hepatic Artery Thrombosis After Liver Transplantation: Five-Year Experience at the State University of Campinas.
    Transplant Proc. 2017;49:867-870.
    PubMed     Text format     Abstract available


    April 2017
  28. KIR O, Zeytinoglu A, Arda B, Yilmaz M, et al
    Impact of Prophylaxis vs Pre-emptive Approach for Cytomegalovirus Infection in Kidney Transplant Recipients.
    Transplant Proc. 2017;49:537-540.
    PubMed     Text format     Abstract available


    March 2017
  29. RUAN V, Czer LS, Awad M, Kittleson M, et al
    Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review.
    Transplant Proc. 2017;49:253-259.
    PubMed     Text format     Abstract available


    January 2017
  30. SHI Y, Liu H, Chen XG, Shen ZY, et al
    Comparison of Mizoribine and Mycophenolate Mofetil With a Tacrolimus-Based Immunosuppressive Regimen in Living-Donor Kidney Transplantation Recipients: A Retrospective Study in China.
    Transplant Proc. 2017;49:26-31.
    PubMed     Text format     Abstract available


    November 2016
  31. LUNA E, Caravaca F, Ferreira F, Fernandez N, et al
    Effect of Cytomegalovirus Infection on Survival of Older Kidney Transplant Patients (D+/R+): Impact of Valganciclovir Prophylaxis Versus Preemptive Therapy.
    Transplant Proc. 2016;48:2931-2937.
    PubMed     Text format     Abstract available


  32. CARBONE J, Gallego A, Fernandez Yanez J, Sousa I, et al
    Potential Immunomodulatory Role of Specific Anticytomegalovirus Intravenous Immunoglobulin in Heart Recipients.
    Transplant Proc. 2016;48:3027-3029.
    PubMed     Text format     Abstract available


    October 2016
  33. FENG S, Yang J, Wang W, Hu X, et al
    Incidence and Risk Factors for Cytomegalovirus Infection in Patients With Kidney Transplantation: A Single-Center Experience.
    Transplant Proc. 2016;48:2695-2699.
    PubMed     Text format     Abstract available


    May 2016
  34. MATSUURA R, Maeda A, Sakai R, Eguchi H, et al
    Human HLA-Ev (147) Expression in Transgenic Animals.
    Transplant Proc. 2016;48:1323-5.
    PubMed     Text format     Abstract available


    April 2016
  35. IWAMOTO H, Nakamura Y, Konno O, Tomita K, et al
    Immunosuppressive Therapy for Elderly Kidney Transplant Recipients.
    Transplant Proc. 2016;48:799-801.
    PubMed     Text format     Abstract available


  36. USHIGOME H, Uchida K, Nishimura K, Akioka K, et al
    Efficacy and Safety of High-Dose Mizoribine Combined With Cyclosporine, Basiliximab, and Corticosteroids in Renal Transplantation: A Japanese Multicenter Study.
    Transplant Proc. 2016;48:794-8.
    PubMed     Text format     Abstract available


    March 2016
  37. ARZE S, Arze L, Abecia C
    Post-transplantation Infections in Bolivia.
    Transplant Proc. 2016;48:646-53.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: